Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory condition of the intestines that is clinically heterogenous. The cause(s) of IBD are currently unknown but the mechanisms of injury are immunological. Increasingly there is an emphasis on the study of the complex interactions at the interface of self and non-self- the gastrointestinal epithelial surface- in relationship to the pathogenesis of disease. There is mounting evidence that a lack of tolerance to the normal commensal flora of the intestine may underly the disease pathogenesis. Several genetic loci that are markers of disease susceptibility have been identified. These loci map to areas of the genome that are concerned with antigen presentation or cytokine secretion and suggest a genetic heterogeneity that underlies the clinical differences. Overall a picture is emerging of defects in epithelial barrier function and, or immunoregulation leading to immune responses that are triggered or exaggerated by the antigenic components of the normal flora.
References
1.
JewellJ.P.Crohn's Disease; Ulcerative Colitis. (1996) In: WetherallD.J., LedinghamJ.G.G., WarrellD.A. (eds) Oxford Textbook of Medicine 3rd edn, Vol. 2. pp. 1936–1950. OUP.
2.
Le RoyD., Di PadovaF., AdachiY., GlauserM.P., CalandraT., & HeumannD. (2001) Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J. Immunol., 167, 2759–2765.
3.
HayashiF., SmithK.D., OzinskyA., HawnT.R., YiE.C., GoodlettD.R., EngJ.K., AkiraS., UnderhillD.M., & AderemA. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature, 410, 1099–1103.
CurfsJ.H., MeisJ.F., & Hoogkamp-KorstanjeJ.A. (1997) A primer on cytokines: sources, receptors, effectors and inducers. Clin. Microbiol. Rev., 10, 742–780.
6.
DelvesP.J., & RoittI.M. (2000) The Immune system. First of two parts. N. Engl. J. Med., 343, 37–49.
7.
DelvesP.J., & RoittI.M. (2000) The Immune system. Second of two parts. N. Engl. J. Med., 343, 108–117.
8.
BerinM.C., McKayD.M., & PerdueM.H. (1999) Immune-epithelial interactions in host defense. Am. J. Trop. Med. Hyg., 60, 16–25.
9.
KronenbergM., & CheroutreH. (2000) Do mucosal T cells prevent intestinal inflammation?Gastroenterology, 118, 974–977.
10.
LammM.E. (1997) Interactions of antigens and antibodies at mucosal surfaces. Ann. Rev. Microbiol., 51, 311–340.
11.
KagnoffM.F., & EckmannL. (1997) Epithelial cells as sensors for microbial infection. J. Clin. Invest., 100, 6–10.
12.
BarnesP.J., & KarinM. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336, 1066–1071.
13.
FrenchN., & PetterssonS. (2000) Microbe-host interactions in the alimentary tract: the gateway to understanding inflammatory bowel disease. Gut, 47, 162–163.
14.
HoldemanL.V., GoodI.J., & MooreW.E.C. (1976) Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl. Environ. Microbiol., 31, 359–375.
15.
SavageD.C. (1983) Morphological diversity among members of the gastrointestinal microflora. Int. Rev. Cytol., 82, 305–334.
16.
SteegeJ.C., BuurmanW.A., & ForgeP.P. (1997) The neonatal development of intraepithelial and lamina propria lymphocytes in the murine small intestine. Dev. Immunol., 5, 121–128.
17.
HooperL.V., WongM.H., ThelinA., HanssonL., FalkP.G., & GordonJ.I. (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science, 291, 881–884.
18.
SimeckaJ.W. (1998) Mucosal immunity of the gastrointestinal tract and oral tolerance. Adv. Drug. Deliv. Rev., 34, 235–259.
19.
ErnstP.B., SongF., KlimpelG.R., HaeberleH., BamfordK.B., CroweS.E., YeG., & ReyesV.E. (1999) Regulation of the mucosal immune response. Am. J. Trop. Med. Hyg., 60, 2–9.
20.
IwasakiA., & KelsallB.L. (1999) Mucosal immunity and inflammation. I Mucosal dendritic cells: their specialized role in initiating T cell responses. Am. J. Physiol. Gastrointest. Liver Physiol., 276, G1074–G1078.
21.
Mac DonaldT.T., & MonteleoneG. (2001) IL-12 and Th1 immune responses in human Peyer's patches. Trends Immunol., 22, 244–247.
22.
van ParijsL., & AbbasA.K. (1998) Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science, 280, 243–248.
23.
FowlerE., & WeinerH.L. (1997) Oral tolerance: Elucidation of mechanisms and application to treatment of autoimmune diseases. Biopoly, 43, 323–335.
GrouxH., O'GarraA., BiglerM., RouleauM., AntonenkoS., de VriesJ.E., & RoncaroloM.G. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 389, 737–742.
26.
GrouxH., & PowrieF. (1999) Regulatory T cells and inflammatory bowel disease. Immunol. Today., 20, 442–445.
27.
van de MerweJ.P., SchroderA.M., WensinckF., & HazenbergM.P. (1988) The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand. J. Gastroenterol., 23, 1125–1131.
28.
DuchmannR., KaiserI., HermannE., MayetW., EweK., & Meyerzum BuschenfeldeK.H. (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol., 102, 448–455.
29.
SatsangiJ., ParkesM., LouisE., HashimotoL., KatoN., WelshK., TerwilligerJ.D., LathropG.M., BellJ.I., & JewellD.P. (1996) Two stage genome wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature (Genet), 14, 199–202.
30.
ToyodaH., WangS.J., YangH.Y., RedfordA., MagalongD., TyanD., McElreeC.K., PressmanS.R., ShanahanF., & TarganS.R. (1993) Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology, 104, 741–748.
31.
StokkersP.C., ReitsmaP.H., TytgatG.N., & van DeventerS.J. (1999) HLA-DR and DQ phenotypes in IBD- a meta analysis. Gut, 45, 395–401.
32.
de la ConchaE.G., Fernandez-ArqueroM., Lopez-NavaG., MartinE., AllcockR.J., ConejeroL., ParedesJ.G., & Diaz-RubioM. (2000) Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology.119, 1491–1495.
33.
OguraY., BonenD.K., InoharaN, NicolaeD.L., ChenF.F., RamosR, BrittonH, MoranT., KaraliuskasR., DuerrR.H., AchkarJ.P., BrantS.R., BaylessT.M., KirschnerB.S., HanauerS.B., NunezG., & ChoJ.H. (2001) A frameshift mutation in NOD 2 associated with susceptibility to Crohn's disease. Nature, 411, 603–606.
DombrowiczD., NuttenS., DesreumauxP., NeutC., TorpierG., PeetersM., ColombelJ.F., & CapronM. (2001) Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation. J. Exp. Med., 193, 25–34.
36.
RathH.C., SchultzM., FreitagR., DiemanL.A., LiF., LindeH.J., ScholmerichJ., & SartorR.B. (2001) Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun., 69, 2277–2285.
37.
CahillR.J., FoltzC.J., FoxJ.G., DanglerC.A., PowrieF., & SchauerD.B. (1997) Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun., 65, 3126–3131.
38.
ShomerN.H., DanglerC.A., SchrenzelM.D., & FoxJ.G. (1997) Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect. Immun., 65, 4858–4864.
39.
KullbergM.C., WardJ.M., GorelickP.L., CasparP., HienyS., CheeverA., JankovicD., & SherA. (1998) Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice though an IL-12-and gamma interferon-dependent mechanism. Infect. Immun., 66, 5157–5166.
CampieriM., & GionchettiP. (2001) Bacteria as the cause of ulcerative colitis. Gut, 48, 132–135.
42.
CaradonnaL., AmatiL., MagroneT., PellegrinoN.M., JirilloE., & CaccavoD. (2000) Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin. Res., 6, 205–214.
43.
BlaserM.J. (1999) Hypothesis: the changing relationships of Helicobacter pylori and humans: Implications for health and disease. J. Infect. Dis., 179, 1523–1530.
44.
TottenP.A., FennellC.L., TenoverP.C., WezenbergJ.M., PerineP.L., StammW.E., & HolmesK.K. (1985) Campylobacter cinaedi and Campylobacter fennelliae two new campylobacter species associated with enteric disease in homosexual men. J. Infect. Dis., 151, 131–139.
45.
SaundersK.E., ShenZ., DewhirstF.E., PasterB.J., DanglerC.A., & FoxJ.G.(1999) Novel intestinal Helicobacter species isolated from Cotton-Top Tamarins (Saguinus Oedipus) with Chronic Colitis. J. Clin. Microbiol., 37, 146–151.
46.
DanonS.J., GohK.L., ParasakthiN., NeilanB.A., GrehanM.J., & LeeA. (2000) The human colon: a reservoir for Helicobacter species. Gut, 47, A2.
47.
OliveiraA.G., QueirozD.M.M.M., RochaG.A., RochaA.M.C., SantosA., SanaM.G.P., MouraS.B., CorreaP.R.V., & CamargosE.R.S. (2001) Isolation of Helicobacter strains from the colonic mucosa of inflammatory bowel disease (IBD) patients. Gut, 49, A1.
48.
GrehanM.J., & DanonS.J. (2001) Absence of Helicobacter species in the ileum and colon of Australians with and without inflammatory bowel disease (IBD) – Should we be looking at other mucus-associated bacteriaGastroenterology, 120 (Supp. 1), A-337.
DuchmannR., MayE., HeikeM., KnollC.P., NeurathK.H., & Meyer zum BuschenfeldeK.H. (1999) T cell specificity and cross reactivity towards entero-bacteria, Bacteroides, Bifidobacterium and antigens from resident intestinal flora in humans. Gut, 44, 812–818.
53.
MuyzerG., & SmallaK. (1998) Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) in microbial ecology. Antonie van Leeuwenhoek, 73, 127–141.
54.
RhodesJ.M. (1997) Colonic mucus and ulcerative colitis. Gut, 40, 807–808.
FavierC., NeutC., MizonC., CortotA., ColombelJ.F., & MizonJ. (1997) Fecal b-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig. Dis. Sci., 42, 817–822.
57.
MadsenK.L., DoyleJ.S., JewellL.D., TaverniniM.M., & FedorakR.N. (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology, 116, 1107–1114.
58.
GionchettiP., RizzelloF., VenturiA., & CampieriM. (2000) Probiotics in infective diarrhoea and inflammatory bowel diseases. J. Gastroenterol. Hepatol., 15, 489–493.
59.
Alvarez-OlmosM.I., & OberhelmanR.A. (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin. Infect. Dis., 32, 1567–1576.
60.
UlisseS., GionchettiP., D'AloS., RussoF.P., PesceI., RicciG., RizzelloF., HelwigU., CifoneM.G., CampieriM., & De SimoneC. (2001) Expression of cytokines, inducible nitric oxide synthase, and matrix metallo-proteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol., 96, 2691–2699.
61.
BlumbergR.S., SaubermannL.J., & StroberW. (1999) Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol., 11, 648–656.
62.
OkamotoS., WatanabeM., YamazakiM., YajimaT., HayashiT., IshiiH., MukaiM., YamadaT., WatanabeN., JamesonBA., & HibiT. (1999) A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis. Eur. J. Immunol., 29, 355–366.
63.
PizarroT.T., ArseneauK.O., & CominelliF. (2000) Lessons from genetically engineered animal models XI. Novel mouse models to study pathogenic mechanisms of Crohn's disease. Am. J. Physiol. Gastrointest. Liver Physiol., 278, G665–669.
64.
PlevyS.E., LandersC.J., PrehnJ., CarramanzanaN.M., DeemR.L., ShealyD., & TarganS.R. (1997) A role for TNF alpha and mucosal Th1 cytokines in the pathogenesis of Crohn's disease. J. Immunol., 159, 6276–6282.
65.
NeurathM.F., FinottoS., FussI., BoirivantM., GalleP.R., & StroberW. (2001) Regulation of T cell apoptosis in IBD: to die or not to die that is the mucosal question. Trends Immunol., 22, 21–26.
66.
UeyamaH., KiyoharaT., SawadaN., IsozakiK., KitamuraS., KondoS., MiyagawaJ., KanayamaS., ShinomuraY., IshikawaH., OhtaniT., NezuR., NagataS., & MatsuzawaY. (1998) High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut, 43, 48–55.
67.
KohoutP., & KorefP. (2001) Intestinal permeability in relatives of patients with Crohn's disease. Vnitr. Lek., 47, 371–374.
68.
IrvineE.J., & MarshallJ.K. (2000) Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology, 119, 1740–1744.
69.
ZareieM., SinghP.K., IrvineE.J., ShermanP.M., McKayD.M., & PerdueM.H. (2001) Monocyte/macrophage activation by normal bacteria and bacterial products. Implications for altered epithelial function in Crohn's disease. Am. J. Pathol., 158, 1101–1109.
70.
GasslerN., RohrC., SchneiderA., KartenbeckJ., BachA., ObermullerN., OttoH.F., & AutschbachF. (2001) Inflammatory bowel disease is associated with changes of enterocyte junctions. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G216–G228.
71.
CarioE., & PodolskyD.K. (2000) Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR 3) and TLR4 in inflammatory bowel disease. Infect. Immun., 68, 7010–7117.
72.
AbreuM.T., VoraP., FaureE., ThomasL.S., ArnoldE.T., & ArditiM. (2001) Decreased expression of Toll-like receptor 4 and MD2 correlate with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol., 167, 1609–1617.
